FMP

FMP

Enter

Geron Corporation's Financial Analysis in the Competitive Biopharmaceutical Landscape

- (Last modified: Mar 12, 2025 3:50 PM)

twitterlinkedinfacebook
blog post cover photo

Image credit: Google Images

Geron Corporation (NASDAQ:GERN) is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for cancer treatment. The company's primary product candidate is imetelstat, a telomerase inhibitor, which is in clinical trials for hematologic myeloid malignancies. Geron operates in a competitive landscape with peers like Stem, Inc., Agenus Inc., and Exelixis, Inc., each with varying degrees of capital efficiency.

Geron Corporation's financial metrics reveal a challenging situation. With a Weighted Average Cost of Capital (WACC) of 8.25% and a Return on Invested Capital (ROIC) of -34.35%, Geron is not generating returns that exceed its cost of capital. This negative ROIC suggests inefficiencies in how the company utilizes its capital, which is a concern for investors looking for effective capital management.

In comparison, Stem, Inc. has a WACC of 4.61% and an ROIC of -0.09%. While Stem also has a negative ROIC, its ROIC to WACC ratio of -0.02 is closer to zero than Geron's -4.16. This indicates that Stem is slightly more efficient in its capital utilization, although it still falls short of covering its cost of capital.

Agenus Inc. presents a stark contrast with a WACC of 88.78% and an impressive ROIC of 302.53%. Its ROIC to WACC ratio of 3.41 highlights its strong ability to generate returns well above its cost of capital. This makes Agenus the most efficient among its peers in terms of capital utilization, suggesting robust growth potential.

Exelixis, Inc. also demonstrates effective capital utilization with a WACC of 6.63% and an ROIC of 18.19%. Its ROIC to WACC ratio of 2.74 indicates a solid performance, though not as high as Agenus. Exelixis's positive ROIC suggests it is effectively using its capital to generate returns, making it an attractive option for investors seeking efficient capital management.

Other Blogs

May 27, 2024 3:30 PM - Rajnish Katharotiya

The best 5 GPU stocks other than NVDA

In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...

blog post title

Jun 10, 2024 3:46 AM - Parth Sanghvi

Fixed Costs vs Variable Costs: Understanding Cost Structures

Understanding the difference between fixed and variable costs is essential for managing a business’s finances. These costs form the foundation of any cost structure and play a critical role in pricing, budgeting, and profit margin analysis. In this guide, we will explore what fixed and variable cost...

blog post title

Jul 10, 2024 2:34 AM - Parth Sanghvi

Capital Budgeting Techniques: NPV, IRR, and More - A Comprehensive Guide

Capital budgeting is a critical financial process that companies use to evaluate and select long-term investments or projects. It involves assessing potential expenditures and determining their profitability to ensure that resources are allocated effectively. This comprehensive guide covers essentia...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep